Site Search
247 Results (showing 1 - 25)
Dec 28, 2001
TRENDSPOTTER: Revolving IPO Door, Consolidation, and Some Cash Await Genomics Sector in 2002
Being the last TrendSpotter column of the year gives me the privilege of looking back on how our industry f
Dec 28, 2001
Pharmacopeia Issues Plea to Block Shareholder s Bid to Dash Eos Acquisition
LOS ANGELES, Dec.
Dec 27, 2001
Incogen Relocates to Virginia for VBI, College of William and Mary Collaboration
NEW YORK, Dec.
Dec 27, 2001
FEATURE: NASA Launches Into Genome Space from Silicon Valley
SAN FRANCISCO, Dec. 27 – The gray brick building that houses the Astrobiology and Life Sciences Laboratories looks out of place on the NASA Ames campus.
Dec 26, 2001
FEATURE: Genomics Sector, Entering Adolescence, Girds for a Realignment in 2002
NEW YORK, Dec. 26 - Sequencing the human genome was widely expected to produce a wealth of new drug targets, and the genomics startups that burst onto the...
Dec 26, 2001
Compugen Goes for Dual Listing on the Tel Aviv Stock Exchange
NEW YORK, Dec. 26 – Compugen, an Israeli bioinformatics company that trades on the Nasdaq stock exchange, said Wednesday that it had received approval to...
Dec 26, 2001
Visible Genetics Pockets $22M in Private Share Placement
NEW YORK, Dec. 26 - Visible Genetics has secured $22 million in a private placement of some 2.6 million common shares, the company said on Wednesday. The funds will be used for general working capital purposes, Visible Genetics said.
Dec 24, 2001
It would be an understatement to say that bioinformatics witnessed its share of ups and downs this year. Subscribers: click headline for more
Dec 24, 2001
Subscribers: click headline for more
Dec 24, 2001
IBM continued its penetration of the proteomics market last week, as protein database provider GeneFormatics chose the company to provide computing equipment and support. Subscribers: click headline for more
Dec 24, 2001
More than 700 people assembled in Tokyo December 17-19 for the 12th International Conference on Genome Informatics, firmly establishing its reputation as a major meeting in a scientifically and commercially important region. Subscribers: click headline for more
Dec 24, 2001
The Buffalo Center of Excellence in Bioinformatics, proposed earlier this year by New York governor George Pataki, is well on its way to becoming a reality with $50 million in state funding and more than $150 million in private-sector funding. Subscribers: click headline for more
Dec 24, 2001
When Applied Biosystems introduced a commercial version of the ICAT reagent technology last March, proteomics researchers had high hopes that at long last a method for performing high-throughput differential protein analysis had emerged to provide an alternative to the drudgery of 2D gel electrophoresis. Subscribers: click headline for more
Dec 24, 2001
Subscribers: click headline for more
Dec 24, 2001
As the International Society for Computational Biology continues to expand and its members hail from an increasingly broader range of disciplines, the challenges for the society multiply in lockstep. Subscribers: click headline for more
Dec 24, 2001
Pharmaceutical companies have long relied on x-ray crystallography to help refine their candidate small molecule drugs, but a deal signed last week between Structural Genomix (SGX) of San Diego and Heidelberg-based Graffinity may be the first to combine the new breed of high-throughput protein crystallography with array-based approaches to finding drug leads. Subscribers: click headline for more
Dec 24, 2001
Two Munich startups, Nanotype and Xerion Pharmaceuticals, have joined forces to develop a protein chip for studying neural stem cell behavior and differentiation, Nanotype said Dec. 13. Subscribers: click headline for more
Dec 24, 2001
Pfizer, Oxford GlycoSciences, Proteome Systems, Millipore, Bruker AXS, Integrative Proteomics
Premium
Subscribers: click headline for more
Dec 21, 2001
Gene Logic, Pfizer to Develop Toxicogenomics Database
NEW YORK, Dec. 21 - Gene Logic has struck a new partnership with Pfizer to co-develop a toxicogenomics database to screen the drug giant's compound library,...